dbs-paper-alternative-vams-micro-blood-sampling

the best alternative
to dried blood spot collection

Learn why it's time to stop using DBS cards!

Download Now

 
Die Alternative zu den DBS-Karten

VAMS® is the technology behind our user-friendly Mitra® devices, which are designed for remote specimen collection. VAMS retains the benefits of dried blood spot collection (DBS) cards while solving for their limitations. Overcome the hematocrit issue with Mitra and VAMS for easy and precise specimen collection, with reliable results. 

case-studies-covers

Download these case studies for details on how to achieve the following benefits vs DBS cards: 

  • Superior analytical performance
    with better correlation to plasma

  • Simple, user-friendly dried blood collection approach
  • Compatibility with 96-well formats for fast sample extractions
  • Collect a homogeneous sample every time with fewer rejects 
next-generation-dbs-device

Mitra® microsampling combines the best of traditional wet sampling and dried blood spotting in a state-of-the-art collection device.

  • Collect a fixed volume (10, 20, or 30 μL) with < 4% RSD
  • Reduce sample rejection rates with high quality blood samples
  • Overcome the volumetric hematocrit (HCT) effect
  • Simple, accurate self-collection with minimal training
  • Easily inserted into common laboratory workflows

Download Now

When DBS cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation.

Yet, adoption was hindered by regulatory concerns over the "Hematocrit (HCT) Effect" and automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.

The Mitra® Microsampler is a remote specimen collection device that retains the advantages of DBS cards while overcoming their limitations.

Download Now

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Trajan_logo_footer_wht

Contact Us
Trajan Scientific Americas Inc.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. 

In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. 

Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group. 

Copyright © 2022. All rights reserved.